Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2024

Nov 5, 2024

29745_dirs_2024-11-05_582c533e-b6c9-4849-894c-d101bd399491.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-11-01

Reporting Person: Hernandez Edgardo (EVP & Pres., Mfg. Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-01 Common Stock M 1687 Acquired 31369 Direct
2024-11-01 Common Stock F 750.799 $818.93 Disposed 30618.201 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-01 Restricted Stock Unit $ M 1687 Disposed 2024-11-01 Common Stock (1687) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 865.22 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.